Cargando…
Establishment of gastric signet ring cell carcinoma organoid for the therapeutic drug testing
Signet ring cell carcinoma (SRCC) has specific oncogenesis and phenotypic and treatment resistance heterogeneity. Systemic therapies are often ineffective, and predictive biomarkers to guide treatment are urgently needed. Tumor organoids have recently emerged as an ideal model for drug testing and s...
Autores principales: | Li, Guoliang, Ma, Shuai, Wu, Quanyou, Kong, Defeng, Yang, Zhenrong, Gu, Zhaoru, Feng, Lin, Zhang, Kaitai, Cheng, Shujun, Tian, Yantao, Zhang, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748936/ https://www.ncbi.nlm.nih.gov/pubmed/35013129 http://dx.doi.org/10.1038/s41420-021-00803-7 |
Ejemplares similares
-
SIRPα antibody combined with oncolytic virus OH2 protects against tumours by activating innate immunity and reprogramming the tumour immune microenvironment
por: Kong, Defeng, et al.
Publicado: (2022) -
Single-cell transcriptomics of peripheral blood reveals anti-tumor systemic immunity induced by oncolytic virotherapy
por: Wu, Quanyou, et al.
Publicado: (2022) -
Telomerase positive CTCs with PSMA high expression associated with prostate cancer metastasis
por: Yang, Zhenrong, et al.
Publicado: (2022) -
Construction and validation of a chemokine family-based signature for the prediction of prognosis and therapeutic response in colon cancer
por: Zhang, Wen, et al.
Publicado: (2023) -
Correlation between PD-L1 expression ON CTCs and prognosis of patients with cancer: a systematic review and meta-analysis
por: Kong, Defeng, et al.
Publicado: (2021)